1 | A multicenter access and distribution protocol for unlicensed cryopreserved cord blood units (CBUs) | - | - | - | - | [1] 60 60 |
2 | A single blood sample for HLA typing | - | - | - | - | [3] 35 35, 38, 162 |
3 | ADA Umbilical Cord Blood Cells | - | - | - | - | [1] 65 65 |
4 | Allogeneic peripheral blood stem cell | - | - | - | - | [1] 65 65 |
5 | Anti-blood dendritic cell antigen 2 | - | - | - | - | [1] 49 49 |
6 | Autologous (self) mononuclear cells derived from umbilical cord blood | - | - | - | - | [1] 211 211 |
7 | Autologous CD34-selected peripheral blood stem cells transplant | - | - | - | - | [1] 96 96 |
8 | Autologous Umbilical Cord Blood | - | - | - | - | [2] 211 211, 294 |
9 | Blood | - | - | - | - | [1] 46 46 |
10 | Blood and stools samples | - | - | - | - | [1] 96 96 |
11 | Blood and urine sampling | - | - | - | - | [1] 195 195 |
12 | Blood and/or skin biopsy | - | - | - | - | [2] 90 90, 301 |
13 | Blood assays | - | - | - | - | [1] 113 113 |
14 | Blood coagulation Factor VIII and vWF, human | [1] Beroctocog alfa Beroctocog alfa | - | - | - | [1] 288 288 |
15 | Blood coagulation factor XIII | [1] Factor XIII (human) Factor XIII (human) | - | - | - | [1] 51 51 |
16 | Blood collection | - | - | - | - | [2] 229 229, 271 |
17 | Blood draw | - | - | - | - | [1] 6 6 |
18 | Blood draw for the laboratory assessment | - | - | - | - | [1] 303 303 |
19 | Blood or Saliva Sample Collection | - | - | - | - | [1] 299 299 |
20 | Blood sample | - | - | - | - | [20] 8 8, 13, 46, 49, 51, 53, 61, 66, 84, 88, 96, 97, 107, 127, 235, 274, 280, 288, 294, 299 |
21 | Blood sample and environmental survey | - | - | - | - | [1] 2 2 |
22 | Blood sample collection | - | - | - | - | [1] 85 85 |
23 | Blood samples | - | - | - | - | [9] 13 13, 41, 51, 61, 97, 227, 240, 271, 280 |
24 | Blood sampling | - | - | - | - | [5] 13 13, 46, 49, 51, 96 |
25 | Blood Sampling and DNA collection | - | - | - | - | [1] 6 6 |
26 | Blood sampling for biological and genetic analysis | - | - | - | - | [1] 19 19 |
27 | Blood test | - | - | - | - | [6] 36 36, 51, 107, 113, 162, 299 |
28 | Blood tests | - | - | - | - | [2] 46 46, 263 |
29 | BNP blood sample test | - | - | - | - | [1] 58 58 |
30 | Collect of 10 ml of peripheric blood for DNA extraction | - | - | - | - | [1] 46 46 |
31 | Collection of biological sample (blood and/or CSF) | - | - | - | - | [2] 2 2, 6 |
32 | Collection of blood and urine | - | - | - | - | [1] 25 25 |
33 | Collection of samples of blood and urine | - | - | - | - | [1] 167 167 |
34 | Cord blood | - | - | - | - | [1] 60 60 |
35 | Cord blood sampling | - | - | - | - | [1] 227 227 |
36 | Cord Blood Transplant | - | - | - | - | [1] 60 60 |
37 | Cord Blood Units | - | - | - | - | [1] 60 60 |
38 | Donor peripheral blood stem cells. | - | - | - | - | [1] 65 65 |
39 | Dried blood spot (DBS) sampling | - | - | - | - | [1] 19 19 |
40 | Extra blood draw samples | - | - | - | - | [1] 300 300 |
41 | Frameshift Array blood sample test | - | - | - | - | [1] 34 34 |
42 | Genetically modified autologous blood stem cells | - | - | - | - | [1] 65 65 |
43 | Human glucocerebrosidase gene into autologous peripheral blood stem cells | - | - | - | - | [1] 19 19 |
44 | Human Umbilical Cord Blood-derived Mesenchymal Stem Cells | - | - | - | - | [1] 36 36 |
45 | Humanised IgG1 monoclonal antibody against blood dendritic cell antigen 2 | - | - | - | - | [1] 49 49 |
46 | One additional blood sample during a planned blood test | - | - | - | - | [1] 266 266 |
47 | Perform blood cells and fibroblasts biochemical and immuno-labeled investigations | - | - | - | - | [1] 265 265 |
48 | Peripheral blood stem cell | - | - | - | - | [1] 285 285 |
49 | Peripheral Blood Stem Cells | - | - | - | - | [2] 51 51, 65 |
50 | Pheripheral blood stem cells | - | - | - | - | [1] 65 65 |
51 | Red Blood Cell Zn | - | - | - | - | [1] 299 299 |
52 | Subretinal injection of umbilical cord blood platelet-rich plasma (CB-PRP) | - | - | - | - | [1] 90 90 |
53 | Taking peripheral blood samples | - | - | - | - | [1] 49 49 |
54 | The POP02 study is collecting bodily fluid samples (i.e., whole blood, effluent samples) of children prescribed the following drugs of interest per standard of care: | - | - | - | - | [1] 86 86 |
55 | Umbilical Cord Blood | - | - | - | - | [1] 60 60 |
56 | Umbilical cord blood (UCB) | - | - | - | - | [1] 60 60 |
57 | Umbilical Cord Blood After Myeloablative Conditioning | - | - | - | - | [1] 60 60 |
58 | Umbilical Cord Blood After Reduced-Intensity Conditioning | - | - | - | - | [1] 60 60 |
59 | Umbilical cord blood mononuclear cells | - | - | - | - | [1] 97 97 |
60 | Umbilical Cord Blood Transplantation | - | - | - | - | [1] 60 60 |
61 | Umbilical Cord Blood Unit | - | - | - | - | [1] 333 333 |
62 | Unrelated cord blood | - | - | - | - | [1] 65 65 |
63 | Unrelated Umbilical Cord Blood Transplant | - | - | - | - | [1] 19 19 |
64 | Venous blood sample | - | - | - | - | [1] 46 46 |
65 | Whole blood sample | - | - | - | - | [1] 177 177 |